HHS officially created a federal health research agency within NIH and named an interim deputy director, in today’s brief health and hospital industry news from the District of Columbia, Kansas and Maryland.
- District of Colombia: HHS Secretary Xavier Becerra officially established the Advanced Health Research Project Agency (ARPA-H) – a $6.5 billion agency that aims to strengthen the federal government’s ability to effectively produce biomedical and health research. Becerra has named Adam Russell as the agency’s interim deputy director, effective June. Currently, Russell is Chief Scientist at the University of Marylandit is Applied Research Laboratory for Intelligence and Security. He has over 10 years of experience as a program manager, first with the Advanced Intelligence Research Projects Activity then with the Advanced Defense Projects Agency. In his new role, Russell will oversee the early stages of building ARPA-H’s administrative structure and manage the hiring of the agency’s first operational employees. Going forward, President Joe Biden will appoint an ARPA-H Director for Administration and Operations, who will report directly to Becerra. “We are thrilled that Dr. Adam Russell has accepted the challenge to help launch ARPA-H, President Biden’s bold new endeavor to support ambitious and potentially transformational health research in this country,” Becerra said. “ARPA-H will have a single goal: to make breakthroughs in health, including the prevention, detection and treatment of diseases such as cancer, Alzheimer’s disease and diabetes.” (Emerson, Becker Hospital Review05/26)
- Kansas: The University of Kansas Health System last week, Scott Campbell named the CEO of its St. Francis campus in Topeka, effective June 27. Campbell, who has more than 30 years of experience in healthcare leadership, most recently served as CEO of UT Health Athens and as a regional leader for UT Health Jacksonville, UT Health Quitmanand UT Health Pittsburgh. He also previously served as CEO of Bay Medical Center Sacred Heart Health. He succeeds Steve Anderson, who is retiring to start a private business in Salt Lake City. (gooch, Becker Hospital Review05/26)
- Maryland: FDA Thursday announced that Abbott recalled certain lots of its Dragonfly OpStar Imaging Catheter due to marker bands that could separate from the catheter after use, remaining in the patient and causing potential injury. Notably, five related incidents and one injury have been reported to the FDA. These catheters are designed to be used for optical coherence tomography of coronary arteries. According to the FDA, suppliers must immediately stop using devices from the affected lots and report all product performance issues to Abbott. (AHA News05/26)